Skip to content

Study of Maternal and Fetal Cardiovascular Function in Hypertensive States of Pregnancy

Study of Maternal and Fetal Cardiovascular Function in Hypertensive States of Pregnancy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06858345
Acronym
CARDIAC-OAT
Enrollment
50
Registered
2025-03-05
Start date
2025-01-01
Completion date
2026-01-15
Last updated
2025-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia

Brief summary

The pharmacological treatment strategy is then tailored to the underlying hemodynamic phenotype of each patient. That is, rather than applying a one-size-fits-all treatment for all patients, therapy is tailored to the specific characteristics of how the cardiovascular system functions in each patient (e.g., whether the problem is more related to blood volume, vascular resistance, cardiac output, etc.). The goal is to personalize therapy to more effectively treat hypertensive states of pregnancy.

Interventions

None listed

Sponsors

Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age greater than or equal to 18 years * Women with singleton and twin pregnancies complicated by hypertensive states of pregnancy.

Exclusion criteria

* Minors under 18 years of age. * Women with mental disabilities. * Major congenital fetal anomaly.

Design outcomes

Primary

MeasureTime frameDescription
Prolongation of at least one week of gestation in pregnancy complicated by hypertensive state of pregnancy with antihypertensive therapy guided by hemodynamic phenotypesUp to 40 weeksNumber of weeks of pregnancy

Countries

Spain

Contacts

Primary ContactCatalina de Paco Matallana, MD
katy.depaco@gmail.com968369500

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026